| Q50800021 | A decade on: what have we learnt about supporting women with intellectual disabilities through the menopause? |
| Q51898531 | A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes. |
| Q74748509 | A validation study on status and age of natural menopause reported in the E3N cohort |
| Q39865144 | Age at menopause and factors associated with attainment of menopause in an urban community in Ibadan, Nigeria |
| Q44367826 | Age at menopause as a risk factor for cardiovascular mortality |
| Q73476648 | Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors |
| Q35560272 | Age-related decline in fertility |
| Q36482458 | Aging and HIV infection |
| Q30664659 | Assignment to menopausal status and estimation of age at menopause for women with missing or invalid data--a probabilistic approach with weighting factors in a large-scale epidemiological study |
| Q50063093 | Association between socioeconomic position in earlier and later life and age at natural menopause: Estudo Pró-Saúde, Brazil |
| Q26740255 | Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition |
| Q44818826 | Associations with age at natural menopause in Blackfeet women |
| Q44466379 | Associations with menopause and menopausal transition in a nationally representative US sample |
| Q37452349 | Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women |
| Q36406735 | Body mass index trajectories and age at menopause in a British birth cohort |
| Q43581448 | Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study |
| Q79227006 | Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants |
| Q35965092 | Cardiovascular disease and primary ovarian insufficiency |
| Q36128333 | Care of the human immunodeficiency virus-infected menopausal woman |
| Q74335722 | Consanguinity and the age of menopause in the United Arab Emirates |
| Q44485914 | Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women |
| Q61713618 | Determinants of age at menopause in Italy: results from a large cross-sectional study |
| Q37041520 | Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women's Health Study |
| Q52801504 | Dietary intake and age at natural menopause: results from the UK Women's Cohort Study. |
| Q28289444 | Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: a systematic review |
| Q40021607 | Early age of natural menopause in India, a biological marker for early preventive health programs |
| Q52194257 | Early menopause in women with Down's syndrome |
| Q44531694 | Effects of menopause on brain structural changes in schizophrenia |
| Q34848049 | Environment, human reproduction, menopause, and andropause |
| Q37419826 | Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly |
| Q44662034 | Estradiol differentially regulates c-Fos after focal cerebral ischemia. |
| Q33913366 | Factors associated with early menopause |
| Q43560409 | Factors associated with menopausal age in Iranian women: Tehran Lipid and Glucose Study |
| Q36974853 | Factors related to age at natural menopause: longitudinal analyses from SWAN. |
| Q78818609 | Gender differences in post-infarction hypertrophy in end-stage failing hearts |
| Q36655162 | HIV and aging: implications for patient management |
| Q46758178 | HIV infection, drug use, and onset of natural menopause |
| Q36562409 | Health issues of menopausal women in North India |
| Q39480542 | Hot flash report and measurement among Bangladeshi migrants, their London neighbors, and their community of origin |
| Q33578853 | Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide |
| Q44660787 | Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women |
| Q28395419 | Life-course origins of the ages at menarche and menopause |
| Q36368694 | Lifestyle factors associated with histologically derived human ovarian non-growing follicle count in reproductive age women |
| Q35406827 | Lifetime socioeconomic position in relation to onset of perimenopause. |
| Q35413742 | Longitudinal study of the inception of perimenopause in relation to lifetime history of sexual or physical violence |
| Q47622177 | Marital status and age at natural menopause: considering pheromonal influence |
| Q35238986 | Menopausal status and physical performance in midlife: findings from a British birth cohort study |
| Q36645280 | Menopause in Egypt: past and present perspectives |
| Q22252912 | Menopause: Adaptation or epiphenomenon? |
| Q39643901 | Menstrual-reproductive factors and age at natural menopause in Iran. |
| Q46968340 | Mid-Aged Health in Women from the Indian Subcontinent (MAHWIS): a further quantitative and qualitative investigation of experience of menopause in UK Asian women, compared to UK Caucasian women and women living in Delhi |
| Q59764204 | Onset of Natural Menopause in African American Women |
| Q26772852 | Perspectives on menopause and women with HIV |
| Q34688088 | Premature ovarian failure (POF): discordance between somatic and reproductive aging |
| Q50605160 | Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65 |
| Q33855741 | Prospective study of factors influencing the onset of natural menopause |
| Q35449838 | Racial and regional differences in age at menopause in the United States: findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
| Q33685214 | Relationship between arsenic skin lesions and the age of natural menopause |
| Q37658818 | Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer |
| Q50621999 | Risk factors of early menopause in two generations of gainfully employed French women. |
| Q41528301 | Secular Trends in Menopause Age |
| Q24813540 | Serum dioxin concentrations and age at menopause |
| Q44576367 | Social and environmental conditions across the life course and age at menopause in a British birth cohort study |
| Q57972433 | The Relationship of Volumetric Breast Density to Socio-Economic Status in a Screening Population |
| Q40877113 | The biological basis of the menopause |
| Q70565102 | The evolution of menopausal symptoms |
| Q35536861 | The menopause and hormone replacement therapy |
| Q73438896 | The menopause transition |
| Q26822580 | The timing of the age at which natural menopause occurs |
| Q50698880 | Time to the final menstrual period. |
| Q34142108 | Trisomic pregnancy and earlier age at menopause |
| Q41118436 | Trisomy and age at menopause: predicted associations given a link with rate of oocyte atresia |
| Q52042587 | Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project. |